Dabigatran vs Ipilimumab

Dabigatran vs Ipilimumab: Overview

This comparison examines the pharmacological differences between Dabigatran and Ipilimumab.

Mechanism of Action

Dabigatran: Direct thrombin (Factor IIa) inhibitor.

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pharmacokinetics

Half-life: Dabigatran — 12-17 hours; Ipilimumab — 14.7 days.

Chemical Properties

Molecular Formula: Dabigatran — C25H25N7O3.

Molecular Weight: Dabigatran — 471.5100 g/mol.

Type: Dabigatran — Small molecule; Ipilimumab — Antibody.